Standout Papers

SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elong... 2020 2026 2022 2024307
  1. SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant (2020)
    Yoriyuki Konno, Izumi Kimura et al. Cell Reports

Immediate Impact

1 by Nobel laureates 18 from Science/Nature 65 standout
Sub-graph 1 of 19

Citing Papers

Mechanisms of long COVID and the path toward therapeutics
2024 Standout
SARS-CoV-2 biology and host interactions
2024 Standout
11 intermediate papers

Works of Izumi Kimura being referenced

Sarbecovirus ORF6 proteins hamper induction of interferon signaling
2021
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
2020 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Izumi Kimura 83 69 402 179 142 17 676
Camille R. Simoneau 76 32 268 251 173 11 652
Emanuela Pelosi 204 39 461 207 94 23 774
Zhenghui Wu 212 13 293 112 182 20 720
Philipp Schommers 129 123 476 136 199 31 841
Florian Wrensch 267 49 482 233 156 19 845
Åsa Hidmark 86 19 235 263 105 23 596
Shannon M. Kahan 140 42 317 316 58 15 706
Daniel Mayer 270 47 245 285 66 16 630
Philippe Monteyne 312 23 151 231 95 31 750
Melissa Cipolla 79 25 428 392 144 12 795

All Works

Loading papers...

Rankless by CCL
2026